HIV prevalence among women in cross-sectional screening by age group and research site
| Bloemfontein | Rustenburg | |
| Age 18–24 | ||
| Eligible population*, N | 776 | 369 |
| HIV positive, N | 104 | 69 |
| Prevalence (95% CI†) | 13.4% (11.0% to 15.8%) | 18.7% (14.7% to 22.7%) |
| Age 25–29 | ||
| Eligible population*, N | 226 | 110 |
| HIV positive, N | 86 | 35 |
| Prevalence (95% CI†) | 38.1% (31.7% to 44.4%) | 31.8% (23.1% to 40.5%) |
| Age 30+ | ||
| Eligible population*, N | 143 | 61 |
| HIV positive, N | 53 | 23 |
| Prevalence (95% CI†) | 37.1% (29.1% to 45.0%) | 37.7% (25.5% to 49.9%) |
| Total | ||
| Eligible population*, N | 1145 | 540 |
| HIV positive, N | 243 | 127 |
| Prevalence (95% CI†) | 21.2% (18.9% to 23.6%) | 23.5% (19.9% to 27.1%) |